Read the inaugural issue of Pharmacology Research & Perspectives

53417-PRP-journalWe are pleased to announce that Pharmacology Research & Perspectives has now published its inaugural issue. Pharmacology Research & Perspectives is a new journal from the British Pharmacological Society (BPS) and the American Society for Pharmacology & Experimental Therapeutics (ASPET) and promotes research in all areas of pharmacology.   
The editor’s choice articles from the inaugural issue are:  
purple_lock_openGreen fluorescent protein fused to peptide agonists of two dissimilar G protein-coupled receptors: novel ligands of the bradykinin B2 (rhodopsin family) receptor and parathyroid hormone PTH1 (secretin family) receptor
Xavier Charest-Morin, Jean-Philippe Fortin, Marie-Thérèse Bawolak, Robert Lodge and François Marceau    

purple_lock_openEffects of D-amino acid oxidase inhibition on memory performance and long-term potentiation in vivo
Seth C. Hopkins, Una C. Campbell, Michele L. R. Heffernan, Kerry L. Spear, Ross D. Jeggo, David C. Spanswick, Mark A. Varney and Thomas H. Large    

purple_lock_open Cilostazol prevents retinal ischemic damage partly via inhibition of tumor necrosis factor-?-induced nuclear factor-kappa B/activator protein-1 signaling pathway
Fumiya Ishizuka, Masamitsu Shimazawa, Yusuke Egashira, Hiromi Ogishima, Shinsuke Nakamura, Kazuhiro Tsuruma and Hideaki Hara

Read inaugural issue

 Pharmacology Research & Perspectives invites authors to submit research articles and invites submission of several types of special articles. These are:
1. Target validation – publication of negative findings including preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development
2. Drug discovery reviews – strategy, hypotheses and data resulting in a successful therapeutic drug
3. Frontiers in translational medicine – drug and target validation for an unmet therapeutic need
4. Pharmacological hypotheses – reviews that are oriented to inform a novel hypothesis

All articles are published under a Creative Commons License and comply with all open access mandates.